1. Hispa-NICE: A Pipe Dream or a Realistic and Necessary Initiative?

   • Fernando Antoñanzas

   Editorial 23 April 2021 Pages: 481 - 483

2. Direct Medical Costs, Productivity Loss Costs and Out-Of-Pocket Expenditures in Women with Breast Cancer in Latin America and the Caribbean: A Systematic Review

   • Alfredo Palacios
   • Carlos Rojas-Roque
   • Federico Augustovski

   Systematic Review 30 March 2021 Pages: 485 - 502

   

3. Utility Decrements Associated with Adult Overweight and Obesity in Australia: A Systematic Review and Meta-Analysis

   • Joseph Carrello
   • Alison Hayes
   • Thomas Lung

   Systematic Review 22 February 2021 Pages: 503 - 519

   

4. Valuation of SF-6Dv2 Health States in China Using Time Trade-off and Discrete-Choice Experiment with a Duration Dimension

   • Jing Wu
   • Shitong Xie
   • John E. Brazier

   Original Research Article Open access 18 February 2021 Pages: 521 - 535

   

5. Cost-Effectiveness Analysis of Afatinib, Erlotinib, and Gefitinib as First-Line Treatments for EGFR Mutation-Positive Non-Small-Cell Lung Cancer in Ontario, Canada

   • Yong-Jin Kim
   • Mark Oremus
   • Susan Horton

   Original Research Article 31 March 2021 Pages: 537 - 548

   

6. RETRACTED ARTICLE: The EQ-5D-5L Valuation Study in Egypt

   • Sahar A. Al Shabasy
   • Maggie M. Abbassi
   • Samar F. Farid

   Original Research Article Open access 12 March 2021 Pages: 549 - 561

   

7. Cost Effectiveness and Budget Impact of Siponimod Compared to Interferon Beta-1a in the Treatment of Adult Patients with Secondary Progressive Multiple Sclerosis with Active Disease in Switzerland

   • Nadine Schur
   • Kapil Gudala
   • Matthias Schwenkglenks

   Original Research Article Open access 01 April 2021 Pages: 563 - 577

   

8. Multiple Myeloma in Portugal: Burden of Disease and Cost of Illness

   • Manuel Neves
   • Fernanda Trigo
   • Catarina Geraldes

   Original Research Article Open access 31 January 2021 Pages: 579 - 587

9. Using a Modified Delphi Approach to Gain Consensus on Relevant Comparators in a Cost-Effectiveness Model: Application to Prostate Cancer Screening

   • Edna Keeney
   • Howard Thom
   • Sabina Sanghera

   Original Research Article Open access 02 April 2021 Pages: 589 - 600

   

10. Resource Utilization of Patients with Parkinson’s Disease in the Late Stages of the Disease in Germany: Data from the CLaSP Study

    • Christopher Kruse
    • Sabrina Kretschmer
    • Richard Dodel

    Original Research Article Open access 19 March 2021 Pages: 601 - 615